Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05309603 · ClinicalTrials.gov registry record · NA

Alterations in Gait, Strength, and Power After Ruck Marching

A NA study of Fatigue and Exercise, sponsored by State University of New York at Buffalo.

Completed
Registry status
NA
Development phase
26
Enrollment target
1
Study location

NCT05309603: Completed NA study of Fatigue and Exercise, sponsored by State University of New York at Buffalo.

NCT05309603 is a NA study of Fatigue and Exercise that has completed, run by State University of New York at Buffalo. The registered enrollment target is 26 participants, below the 218-participant average among 109 other Fatigue trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05309603, a NA study of Fatigue and Exercise, has completed, sponsored by State University of New York at Buffalo.

COMPLETED
Registry status
NA
Development phase
26 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine change in injury risk and performance variables in males and females after walking unloaded and carrying a load with two different distributions (high-pack placement and mid-pack placement) to identify differences in injury risk

Primary Outcome

Oxygen consumption will be measured using indirect calorimetry

Conditions Studied

Interventions

  • OTHER Walking
  • OTHER Loaded Walking High
  • OTHER Loaded Walking Mid

Study Locations (1)

New York

  • University at Buffalo - Buffalo

Trial Details

FieldValue
Enrollment Target 26 participants
Start Date 2022-03-21
Est. Completion 2023-07-21
Phase NA

What the finished NCT05309603 record still lists

NCT05309603 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 218-participant average among 109 other Fatigue trials with a reported enrollment target (88% lower).

The record links to 2 conditions, with Fatigue appearing as the primary indexed condition, and to 3 interventions - of which Walking is the first listed.

NCT05309603 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT05309603 about?

NCT05309603 is a clinical study titled "Alterations in Gait, Strength, and Power After Ruck Marching". The purpose of this study is to determine change in injury risk and performance variables in males and females after walking unloaded and carrying a load with two different distributions (high-pack placement and mid-pack placement) to identify differences in injury risk

What is the current status of trial NCT05309603?

This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2022-03-21. Estimated completion is 2023-07-21.

What conditions does trial NCT05309603 study?

This clinical trial studies the following conditions: Fatigue, Exercise.

What interventions are being tested in trial NCT05309603?

The interventions under investigation include: Walking (OTHER), Loaded Walking High (OTHER), Loaded Walking Mid (OTHER).

Who is sponsoring clinical trial NCT05309603?

This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05309603 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Fatigue

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05309603's enrollment target sits among peer trials

26 89th of 109 higher than 21 of 109 other Fatigue trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Fatigue trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02646475 · 26 participants · Phase 1

    Metabolic Effects of Angiotensin-(1-7)

  • NCT03603223 · 26 participants · Phase 2

    Pembrolizumab in Treating Participants With Leukoplakia

  • NCT04063592 · 26 participants · NA

    AMI Construction in Lower Extremity Residual Limbs

  • NCT04906460 · 26 participants · Phase 1

    Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05309603, the US trial registry maintained by the National Library of Medicine. NCT05309603 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.